Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Veracur 0.75% gel
1307000C0BBAAAB
|
Veracur | Formaldehyde | Skin | No data available |
|
Verapamil 10mg/5ml oral liquid
0206020T0AAA3A3
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 120mg/5ml oral liquid
0206020T0AABABA
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 180mg modified-release / Trandolapril 2mg capsules
0205051V0AAAAAA
|
Trandolapril/verapamil hydrochloride | Trandolapril with calcium channel blocker | Cardiovascular System | No data available |
|
Verapamil 180mg modified-release capsules
0206020T0AAAJAJ
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 20mg/5ml oral liquid
0206020T0AAA2A2
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 240mg/5ml oral liquid
0206020T0AABHBH
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 250mg/5ml oral liquid
0206020T0AABFBF
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 30mg/5ml oral liquid
0206020T0AABEBE
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 40mg/5ml oral liquid
0206020T0AAAZAZ
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 45mg/5ml oral liquid
0206020T0AABDBD
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 50mg/5ml oral liquid
0206020T0AABGBG
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 5mg/2ml solution for injection ampoules
0206020T0AAAAAA
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 80mg/5ml oral liquid
0206020T0AAA1A1
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapress MR 240mg tablets (Actavis)
0206020T0BHACAH
|
Verapress | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapress MR 240mg tablets (Teva)
0206020T0BHADAH
|
Verapress | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Vericiguat 10mg tablets
0205010ACAAAAAA
|
Vericiguat | Vericiguat | Cardiovascular System | No data available |
|
Vericiguat 2.5mg tablets
0205010ACAAABAB
|
Vericiguat | Vericiguat | Cardiovascular System | No data available |
|
Vericiguat 5mg tablets
0205010ACAAACAC
|
Vericiguat | Vericiguat | Cardiovascular System | No data available |
|
Vernagel 8g powder sachets
190500000BBACA0
|
Proprietary compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
|
Verquvo 2.5mg tablet
0205010ACBBABAB
|
Verquvo | Vericiguat | Cardiovascular System | No data available |
|
Verquvo 5mg tablets
0205010ACBBACAC
|
Verquvo | Vericiguat | Cardiovascular System | No data available |
|
VersaJet Exact handset 45/14mm
21410000102
|
VersaJet Exact handset 45/14mm | Debridement Device | Appliances | No data available |
|
VersaJet Exact handset 45/8mm
21410000101
|
VersaJet Exact handset 45/8mm | Debridement Device | Appliances | No data available |
|
VersaJet II Exact handset 45/14mm
21410000104
|
VersaJet II Exact handset 45/14mm | Debridement Device | Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.